Research discovery

Find the original research

Live search across PubMed, the U.S. National Library of Medicine's citation database, and ClinicalTrials.gov. We show what each record is and link you to it; we don't summarise findings or rank studies by what they conclude.

Published studies · PubMed Clinical trials · ClinicalTrials.gov

Find the original research

Phase 2 Clinical Study of MWN109 Tablets in Participants With Type 2 Diabetes Mellitus (opens ClinicalTrials.gov)

Semaglutide for Smoking Cessation in Patients With Diabetes (opens ClinicalTrials.gov)

A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight (opens ClinicalTrials.gov)

Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes. (opens ClinicalTrials.gov)

A First-in-human Research Study on How NNC0721-8060 Works in People Living With Overweight or Obesity (opens ClinicalTrials.gov)

Weight Loss in Adults Using Semaglutide (Real-world Study) (opens ClinicalTrials.gov)

Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss (opens ClinicalTrials.gov)

Bariatric Surgery vs. Semaglutide vs. Tirzepatide (opens ClinicalTrials.gov)

Semaglutide Therapy for Alcohol Reduction (STAR) (opens ClinicalTrials.gov)

Efficacy and Safety of Empagliflozin or Semaglutide in Overweight/Obese Patients With Type 1 Diabetes (opens ClinicalTrials.gov)

Early Reinitiation of Semaglutide Post-Sleeve Gastrectomy in Youth (opens ClinicalTrials.gov)

Free Fatty Acid Effects In Type 2 Diabetes (opens ClinicalTrials.gov)

A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation (opens ClinicalTrials.gov)

Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary Syndrome (opens ClinicalTrials.gov)

Body Surface Gastric Mapping in Patients on Semaglutide (opens ClinicalTrials.gov)

REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels (opens ClinicalTrials.gov)

A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Single Doses of Different Versions of Injectable CagriSema in Adults With Overweight or Obesity (opens ClinicalTrials.gov)

HMB Plus Vitamin D to Preserve Muscle in Older Adults Starting Semaglutide (opens ClinicalTrials.gov)

GLP-1R Agonist Treatment for Opioid Use Disorder (opens ClinicalTrials.gov)

GLP-1/GIP Receptor Agonists in Obesity-Related HFpEF: The GLIDE-HF Registry (opens ClinicalTrials.gov)